EGFR and hepatocellular carcinoma: The key signaling pathways that cause drug resistance in HCC, including transforming growth factor-β and epidermal growth factor receptor signaling, liver cancer stem cells, and noncoding RNAs, are highlighted in the present study, along with the most recent molecular targets discovered to prevent drug resistance.